Hellstern V, Brenner N, Cimpoca A, Albina Palmarola P, Henkes E, Wendl C, Bäzner H, Ganslandt O, Henkes H
Neuroradiologische Klinik, Neurozentrum, Klinikum Stuttgart, Stuttgart, Germany.
Institut für Röntgendiagnostik, Zentrum für Neuroradiologie, Universitätsklinikum Regensburg, Regensburg, Germany.
Front Neurol. 2024 Aug 14;15:1415861. doi: 10.3389/fneur.2024.1415861. eCollection 2024.
MCA bifurcation aneurysms pose treatment challenges because of the complex hemodynamics at the bifurcation and the risk of rupture. FDS implantation has been controversial and there are only limited reports. Therefore, the aim of this study was to assess the efficacy and safety of this treatment strategy using p64 MW HPC and p48 MW HPC FDSs for MCA bifurcation aneurysms, compared with the p64 classic FDS.
We retrospectively analyzed our institutional database and identified all patients with saccular, non-ruptured MCA bifurcation aneurysms treated with p64 MW HPC, p48 MW HPC, or p64 classic FDS implantation alone. Aneurysms with implantation of additional devices in the same session, previous treatments, and acutely ruptured and fusiform aneurysms were excluded.
A total of 79 aneurysms met the inclusion criteria: 23 receiving a p64 MW HPC, 34 receiving a p48 MW HPC, and 22 receiving a p64 classic FDS. The occlusion rate was highest for the p48 MW HPC 2 mm FDS, at 88.9% at FU2, compared with 72.2% for the p64 MW HPC and 70.6% for the p64 classic. The time to aneurysm occlusion was shortest with the p64 MW HPC, at 178.31 days. The highest retreatment rate was observed with the p48 MW HPC 3 mm.
Treatment of MCA bifurcation aneurysms with a p48 MW HPC 2 mm or p64 MW HPC FDS is a safe and reliable strategy achieving high aneurysm occlusion rates - attributable to their lower porosity in relation to the parent vessel diameter as compared to the p48 MW HPC 3 mm FDS-, with reasonable morbidity and mortality.
大脑中动脉(MCA)分叉处动脉瘤因其分叉处复杂的血流动力学和破裂风险而带来治疗挑战。血流导向装置(FDS)植入一直存在争议,相关报道有限。因此,本研究的目的是评估使用p64兆瓦高孔隙率(MW HPC)和p48兆瓦高孔隙率FDS治疗MCA分叉处动脉瘤的疗效和安全性,并与p64经典FDS进行比较。
我们回顾性分析了本机构数据库,确定了所有仅接受p64兆瓦高孔隙率、p48兆瓦高孔隙率或p64经典FDS植入治疗的囊状、未破裂MCA分叉处动脉瘤患者。排除在同一次手术中植入额外装置、既往接受过治疗、急性破裂和梭形动脉瘤患者。
共有79个动脉瘤符合纳入标准:23个接受p64兆瓦高孔隙率FDS治疗,34个接受p48兆瓦高孔隙率FDS治疗,22个接受p64经典FDS治疗。p48兆瓦高孔隙率2毫米FDS的闭塞率最高,随访2时为88.9%,而p64兆瓦高孔隙率为72.2%,p64经典FDS为70.6%。p64兆瓦高孔隙率FDS使动脉瘤闭塞的时间最短,为178.31天。p48兆瓦高孔隙率3毫米FDS的再治疗率最高。
使用p48兆瓦高孔隙率2毫米或p64兆瓦高孔隙率FDS治疗MCA分叉处动脉瘤是一种安全可靠的策略,可实现较高的动脉瘤闭塞率——这归因于与p48兆瓦高孔隙率3毫米FDS相比,它们相对于母血管直径的孔隙率较低——且具有合理的发病率和死亡率。